Congressional trading
Who in Congress traded BSX?
Boston Scientific Corporation Common Stock · classified as Health care. 14 disclosed transactions across 6 members.
14
Transactions
6
Members
5 / 9
Buys / sells
3
Filed late
Committee overlap
2 of 6 members who traded BSX sit on a committee with jurisdiction over Health care. This is a disclosed structural overlap, not evidence of wrongdoing. Nothing here asserts that any member acted on non-public information. Jurisdiction is mapped from published House and Senate committee rules — see the methodology.
Members
5 transactions1 filed past the 45-day deadline- Sell2025-10-31$1,001 - $15,000(Spouse)disclosed after 1dfiling
- Sell2025-10-30$1,001 - $15,000(Spouse)disclosed after 2dfiling
- Buy2025-10-30$1,001 - $15,000(Spouse)disclosed after 2dfiling
- Partial sell2025-08-04$1,001 - $15,000(Spouse)disclosed after 9dfiling
- Buy2024-12-11$1,001 - $15,000(Spouse)disclosed after 243dfiling
3 transactionsCommittee overlap
2 transactions
2 transactions1 filed past the 45-day deadline
1 transactionCommittee overlap1 filed past the 45-day deadline- Buy2026-03-27$1,001 - $15,000disclosed after 116dfiling
1 transaction- Partial sell2025-10-28$15,001 - $50,000(Joint)disclosed after 1dfiling
Where this comes from
10 transactions from House Clerk Periodic Transaction Reports and 4 from Senate eFD filings. Amounts are the statutory brackets filers report — Congress does not disclose exact values. Senate filings carry one filing date per report rather than per transaction, so “disclosed after” for a Senate row is measured to the date the whole report was filed. This page is a conflict-of-interest disclosure, not investment advice or a trading signal.